UB Paderborn / Katalog / Suche / in CDI

Towards the identification of customer experience touch point elements

Journal of retailing and consumer services, 2016-05, Vol.30, p.8-19

2016

Volltextzugriff (PDF)

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Journal of clinical oncology, 2018-02, Vol.36 (6), p.536-542

2018

Volltextzugriff (PDF)

Firm self-service technology readiness

Journal of service management, 2015-10, Vol.26 (5), p.751-776

2015

Volltextzugriff (PDF)

Connecting the dots between brand experience and brand loyalty: The mediating role of brand personality and brand relationships

The journal of brand management, 2014-11, Vol.21 (7-8), p.664-683

2014

Volltextzugriff (PDF)

High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review

Clinical therapeutics, 2009, Vol.31, p.2371-2378

2009

Volltextzugriff (PDF)

The relationship between comorbidity medication adherence and health related quality of life among patients with cancer

Journal of patient-reported outcomes, 2018-07, Vol.2 (1), p.29-29, Article 29

2018

Volltextzugriff (PDF)

Correction to: The relationship between comorbidity medication adherence and health related quality of life among patients with cancer

Journal of patient-reported outcomes, 2021-03, Vol.5 (1), p.25-25, Article 25

2021

Volltextzugriff (PDF)

The customer experience – loyalty link: moderating role of motivation orientation

Journal of service management, 2020-01, Vol.31 (1), p.51-78

2020

Volltextzugriff (PDF)

Customer Referral Behavior: Do Switchers and Stayers Differ?

Journal of service research : JSR, 2015-05, Vol.18 (2), p.229-239

2015

Volltextzugriff (PDF)

Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15035-e15035

2022

Volltextzugriff (PDF)

Pathogenic fusion detection in solid malignancies utilizing RNA-DNA based comprehensive genomic profiling (CGP) testing

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3078-3078

2022

Volltextzugriff (PDF)

Which patient characteristics drive treatment decisions in elderly patients with early stage hormone receptor–positive breast cancer?

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.538-538

2017

Volltextzugriff (PDF)

An open-label, single-arm, phase II study of pertuzumab with high-dose trastuzumab for treatment of central nervous system (CNS) progression post-radiotherapy in patients (pts) with HER2-positive metastatic breast cancer (MBC): PATRICIA

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS633-TPS633

2016

Volltextzugriff (PDF)

Planned interim analysis of PATRICIA: An open-label, single-arm, phase II study of pertuzumab (P) with high-dose trastuzumab (H) for the treatment of central nervous system (CNS) progression post radiotherapy (RT) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2074-2074

2017

Volltextzugriff (PDF)

Status demotion in hierarchical loyalty programs: effects of payment source

The Service industries journal, 2016-07, Vol.36 (9-10), p.375-395

2016

Volltextzugriff (PDF)

The association between healthy days and patient-reported cancer symptoms in a metastatic cancer population

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18179-e18179

2016

Volltextzugriff (PDF)

Reply to J.J. Tao et al

Journal of clinical oncology, 2018-08, Vol.36 (23), p.2451-2451

2018

Volltextzugriff (PDF)

Is there a relationship between self-reported healthy days and comorbidity medication adherence among oncology patients?

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.189-189

2016

Volltextzugriff (PDF)

Validation of two cancer care plan communication tools

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.145-145

2017

Volltextzugriff (PDF)

How are quality of life and work productivity associated with living longer with HER2+ metastatic breast cancer?

Journal of clinical oncology, 2017-02, Vol.35 (5_suppl), p.215-215

2017

Volltextzugriff (PDF)

Ixabepilone

Clinical journal of oncology nursing, 2010-02, Vol.14 (1), p.65

Stein, Alisha

2010

Volltextzugriff (PDF)

Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study

Journal of clinical oncology, 2016-06, Vol.34 (18_suppl), p.LBA11511-LBA11511

2016

Volltextzugriff (PDF)

Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.LBA11511-LBA11511

2016

Volltextzugriff (PDF)

Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data

Journal of cancer therapy, 2019, Vol.10 (2), p.117-133

2019

Volltextzugriff (PDF)

Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy

Journal of cancer therapy, 2019, Vol.10 (1), p.1-20

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Towards the identification of customer experience touch point elements

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Firm self-service technology readiness

Connecting the dots between brand experience and brand loyalty: The mediating role of brand personality and brand relationships

High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review

The relationship between comorbidity medication adherence and health related quality of life among patients with cancer

Correction to: The relationship between comorbidity medication adherence and health related quality of life among patients with cancer

The customer experience – loyalty link: moderating role of motivation orientation

Customer Referral Behavior: Do Switchers and Stayers Differ?

Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system

Pathogenic fusion detection in solid malignancies utilizing RNA-DNA based comprehensive genomic profiling (CGP) testing

Which patient characteristics drive treatment decisions in elderly patients with early stage hormone receptor–positive breast cancer?

An open-label, single-arm, phase II study of pertuzumab with high-dose trastuzumab for treatment of central nervous system (CNS) progression post-radiotherapy in patients (pts) with HER2-positive metastatic breast cancer (MBC): PATRICIA

Planned interim analysis of PATRICIA: An open-label, single-arm, phase II study of pertuzumab (P) with high-dose trastuzumab (H) for the treatment of central nervous system (CNS) progression post radiotherapy (RT) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Status demotion in hierarchical loyalty programs: effects of payment source

The association between healthy days and patient-reported cancer symptoms in a metastatic cancer population

Reply to J.J. Tao et al

Is there a relationship between self-reported healthy days and comorbidity medication adherence among oncology patients?

Validation of two cancer care plan communication tools

How are quality of life and work productivity associated with living longer with HER2+ metastatic breast cancer?

Ixabepilone

Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study

Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study

Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data

Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy

Suchergebnisse filtern